tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MCRB Stock Latest News

Seres Therapeutics Reports Positive Q3 2025 Results
Company AnnouncementsSeres Therapeutics Reports Positive Q3 2025 Results
27d ago
MCRB
Seres Therapeutics Reports Positive Q3 Earnings Call
PremiumCompany Announcements
Seres Therapeutics Reports Positive Q3 Earnings Call
27d ago
MCRB
Seres Therapeutics Reports Q3 Results and Business Updates
PremiumCompany Announcements
Seres Therapeutics Reports Q3 Results and Business Updates
28d ago
8K
MCRB
Seres Therapeutics reports Q3 EPS 94c vs ($6.69) last year
PremiumThe Fly
Seres Therapeutics reports Q3 EPS 94c vs ($6.69) last year
28d ago
MCRB
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
30d ago
MCRB
Seres Therapeutics receives award of up to $3.6M from CARB-X
PremiumThe FlySeres Therapeutics receives award of up to $3.6M from CARB-X
1M ago
MCRB
Seres Therapeutics to present new post hoc data from SER-155 Phase 1b trial
Premium
The Fly
Seres Therapeutics to present new post hoc data from SER-155 Phase 1b trial
2M ago
MCRB
Seres Therapeutics Cuts Costs to Extend Cash Runway
Premium
Company Announcements
Seres Therapeutics Cuts Costs to Extend Cash Runway
2M ago
8K
MCRB
Seres Therapeutics price target raised to $22 from $14 at Canaccord
PremiumThe Fly
Seres Therapeutics price target raised to $22 from $14 at Canaccord
2M ago
MCRB
Seres Therapeutics announces further constructive feedback from FDA on SER-155
PremiumThe Fly
Seres Therapeutics announces further constructive feedback from FDA on SER-155
2M ago
MCRB
Seres Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Seres Therapeutics’ Earnings Call: Progress Amid Challenges
4M ago
MCRB
Promising Developments and Strategic Partnerships Drive Buy Rating for Seres Therapeutics
PremiumRatings
Promising Developments and Strategic Partnerships Drive Buy Rating for Seres Therapeutics
4M ago
MCRB
Seres Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsSeres Therapeutics Reports Q2 2025 Financial Results
4M ago
MCRB
Seres Therapeutics Reports Q2 Results and Leadership Change
Premium
Company Announcements
Seres Therapeutics Reports Q2 Results and Leadership Change
4M ago
8K
MCRB
Seres Therapeutics reports Q2 EPS ($2.27) vs ($4.34) last year
Premium
The Fly
Seres Therapeutics reports Q2 EPS ($2.27) vs ($4.34) last year
4M ago
MCRB
Seres Therapeutics expects cash to fund operations into Q1 2026
PremiumThe Fly
Seres Therapeutics expects cash to fund operations into Q1 2026
4M ago
MCRB
Seres Therapeutics Announces CEO Resignation and New Appointments
PremiumCompany Announcements
Seres Therapeutics Announces CEO Resignation and New Appointments
4M ago
8K
MCRB
Seres Therapeutics appoints DesRosier, Thorell as co-CEOs
PremiumThe Fly
Seres Therapeutics appoints DesRosier, Thorell as co-CEOs
4M ago
MCRB
Seres Therapeutics presents expanded SER-155 biomarker data at ASCO meeting
PremiumThe Fly
Seres Therapeutics presents expanded SER-155 biomarker data at ASCO meeting
6M ago
MCRB
Buy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
PremiumRatingsBuy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
7M ago
MCRB
Seres Therapeutics downgraded to Neutral from Buy at Chardan
Premium
The Fly
Seres Therapeutics downgraded to Neutral from Buy at Chardan
7M ago
MCRB
Seres Therapeutics Reports Positive Q1 2025 Results
Premium
Company Announcements
Seres Therapeutics Reports Positive Q1 2025 Results
7M ago
MCRB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >